Reuters logo
4 个月前
BRIEF-Replicel says rct-01 tendon repair clinical trial shows signs of healing chronic tendon problems
2017年3月28日 / 上午10点17分 / 4 个月前

BRIEF-Replicel says rct-01 tendon repair clinical trial shows signs of healing chronic tendon problems

1 分钟阅读

March 28 (Reuters) - Replicel Life Sciences Inc:

* Replicel's successful rct-01 tendon repair clinical trial shows signs of healing chronic tendon problems

* Replicel Life Sciences-first-in-human clinical study meets primary endpoint demonstrating product safety, clinical potential for tendon regeneration, healing

* Replicel Life Sciences Inc - clinical trial met its goal of establishing a complete safety profile at 6 months

* Replicel Life Sciences Inc - clinical trial showed no serious adverse events related to study treatment or injection procedure Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below